Evidence map›Paper›PMID 24421815›Full record

ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2013

Molecular identification and susceptibility pattern of clinical Nocardia species: Emergence of Nocardia crassostreae as an agent of invasive nocardiosis.

Saad J Taj-Aldeen, Anand Deshmukh, Sanjay Doiphode, Atqah Abdul Wahab, Mona Allangawi, Ahmed Almuzrkchi, Corné H Klaassen, Jacques F Meis

Open access · goldAbstract read
In one paragraph

Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Septic arthritis caused by Nocardia asiatica: a case report and narrative review.Revista do Instituto de Medicina Tropical de Sao Paulo · 2026
    Review
  3. Detection and Quantification ofPathogens (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Molluscs-A ticking microbial bomb.Frontiers in microbiology · 2022
    Review
  6. Review
  7. International journal of clinical and experimental pathology · 2018
    Article
  8. Assessment of the Health Status of MusselsFrontiers in physiology · 2018
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Saad J Taj-AldeenMicrobiology Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar;
Anand DeshmukhMicrobiology Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar;
Sanjay DoiphodeMicrobiology Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar;
Atqah Abdul WahabDepartment of Pediatric, Hamad Medical Corporation, Doha, Qatar;
Mona AllangawiDepartment of Internal Medicine, Hamad Medical Corporation, Doha, Qatar;
Ahmed AlmuzrkchiDepartment of Radiology, Hamad Medical Corporation, Doha, Qatar;
Corné H KlaassenDepartment of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Jacques F MeisDepartment of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Hamad Medical Corporation · QACanisius-Wilhelmina Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNocardia species are rare, opportunistic organisms that cause disease in both immunocompetent and immunocompromised individuals.

objectiveTo investigate the clinical presentations of various Nocardia infections based on the 16S ribosomal RNA gene of the isolate, as well as related risk factors and susceptibility patterns to antimicrobial agents.

methodsThirteen patients with a diagnosis of nocardiosis were included in the present study. Seven Nocardia species were identified by 16S ribosomal RNA. Susceptibility testing was performed using six antimicrobial agents.

resultsFive patients were immunocompromised, and eight were immunocompetent with predisposing factors including cystic fibrosis, tuberculosis and ophthalmic infections. Nocardia caused pulmonary infections in eight patients (61.5%), invasive systemic infections in three patients (23%) and local (ophthalmic) infections in two patients (15.4%). In the patients with pulmonary disease, nocardiosis was caused by six species (Nocardia cyriacigeorgica, Nocardia otitidiscaviarum, Nocardia farcinica, Nocardia carnea, Nocardia testacea and Nocardia asiatica). The seventh species identified in the present study was Nocardia crassostreae. DISCUSSION: N crassostreae is a multidrug-resistant organism that was reported to be an emerging human pathogen causing invasive nocardiosis in a patient with non-Hodgkin's lymphoma. N farcinica was isolated from blood in a patient with breast cancer. None of the Nocardia isolates were resistant to linezolid. One N otitidiscaviarum isolate was a multidrug-resistant organism. All patients in the present study were treated with the appropriate antibiotics and their condition resolved without further sequelae.

conclusionsThe present study is the first report on N crassostreae as a human pathogen. The detection of multidrug-resistant species necessitate molecular identification and susceptibility testing, and should be performed for all Nocardia infections. Nocardiosis manifests various clinical features depending on the Nocardia species and underlying conditions.

Indexed as

Antibiotic susceptibilityClinical casesMolecular identificationNocardiaNocardia crassostreae

Identifiers

PMID24421815
PMCPMC3720011
OpenAlexW1753646838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.